Riskpilot← Back to searchSign inGet full accessDalbyoptikerna AB
ABActiveOrg 5567338370Hällestadsvägen 47 BRetail sale of medical and orthopaedic goods · NACE 4774Est. 20072 employees
Revenue 2025
SEK 3,9M
0% vs 2024
EBITDA margin
22.7%
+38% vs 2024
Equity ratio
30.0%
Financial strength
Net profit 2025
SEK 563K
+36% vs 2024
| Revenue | SEK 3,9M | +0% |
| EBITDA | SEK 873K | +38% |
| Net profit | SEK 563K | +36% |
| Total assets | SEK 2,4M | +14% |
| Equity | SEK 716K | +17% |
| Employees | 2 | — |
Legal name
Dalbyoptikerna AB
Org number
5567338370
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
3 juli 2007
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva handel med optik samt därmed förenlig verksamhet.
Address
Hällestadsvägen 47 B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 009 | 3 451 | 3 227 | 3 874 | 3 855 |
| Staff expenses | — | — | — | — | −1 385 |
| EBITDA | 1 157 | 810 | 541 | 633 | 873 |
| Depreciation & amort. | −80 | −110 | −32 | −6 | −6 |
| EBIT | 1 077 | 700 | 509 | 627 | 868 |
| Net financials | — | 1 | 24 | 26 | 19 |
| Profit before tax | 836 | 608 | 443 | 531 | 718 |
| Tax | −175 | −129 | −98 | −117 | −155 |
| Net profit | 661 | 479 | 345 | 414 | 563 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 269 | 2 598 | 1 962 | 2 089 | 2 385 |
| Equity | 1 755 | 1 334 | 659 | 613 | 716 |
| Long-term debt | 80 | 0 | 0 | 0 | — |
| Short-term debt | 601 | 338 | 287 | 339 | 363 |
| Total debt | 681 | 338 | 287 | 339 | 363 |
EBITDA margin
22.7%
This company
15.8%
Market median
+44% vs market
20212025
Equity ratio
30.0%
This company
38.2%
Market median
-21% vs market
20212025
Return on equity
78.6%
This company
18.4%
Market median
+327% vs market
20212025
Net profit margin
14.6%
This company
8.1%
Market median
+80% vs market
20212025
Asset turnover
1.62×
This company
1.12×
Market median
+45% vs market
20212025
Debt / equity
2.33×
This company
0.62×
Market median
-276% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JA | Audit | 2022 |
| Former (1) | ||
TJ Audit | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Welmac AB
Dalbyoptikerna AB Board members of Dalbyoptikerna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jenny Anna-Maria Tobiaeson | Audit | 0 companies |
| Tom Jerry Arnshed | Audit | 0 companies |
| Åse Marie Ingegärd Svahn | Board of Directors | 0 companies |
| Anders Per-Ola Svahn | Deputy Board Member | 0 companies |